Bicara Therapeutics (NasdaqGM:BCAX) Q4 2025 Earnings call March 30, 2026 08:30 AM ET Company ParticipantsClaire Mazumdar - CEOEva Fortea - VP, Equity ResearchIvan Hyep - CFOLana Usmanova - Research AssociateRachel Frank - Senior Director and Head of Investor Relations and Corporate CommunicationsRyan Cohlhepp - President and COOStephen Willey - Managing DirectorTanya Green - Chief Development OfficerConference Call ParticipantsEric Schmidt - AnalystJeet Mukherjee - Biotechnology AnalystJudah Frommer - Equit ...

Bicara Therapeutics (NasdaqGM:BCAX) Q4 2025 Earnings call March 30, 2026 08:30 AM ET Speaker8Good day, and thank you for standing by. Welcome to the Bicara Therapeutics fourth quarter and full year 2025 earnings call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you'll need to press star one one on your telephone. You will then hear an automated message advising your hand is raised ...